High-Intensity Exercise for Older Adults with HIV
(HEALTH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether high-intensity interval training (HIIT) can improve physical function and reduce fatigue in older adults with HIV more effectively than continuous moderate exercise (CME). It also examines whether coaching can help participants maintain long-term exercise habits. The trial seeks participants who are 50 years or older, have had HIV for at least a year, experience fatigue, and lead a sedentary lifestyle. Participants must commit to a 16-week exercise program, three times a week. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance exercise programs for older adults with HIV.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on sex hormone therapy or other hormone replacement, you must have been on a stable dose for more than 3 months. Also, if you are undergoing a muscle biopsy, you may need to stop taking certain medications like aspirin for 7 days before the procedure.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that high-intensity interval training (HIIT) can be safe and effective for older adults with HIV. Studies have examined the feasibility of HIIT and found that this group can manage it well. For instance, one study discovered that HIIT improved heart and lung fitness and endurance in older adults with HIV, with results similar to those from regular moderate exercise.
These studies have reported no major serious side effects from HIIT, suggesting that it could be a safe way to boost physical health in older adults with HIV. However, as with any exercise program, participants should start slowly and maintain communication with their healthcare providers throughout.12345Why are researchers excited about this trial?
Researchers are excited about exploring high-intensity exercise for older adults with HIV because it offers a novel approach to managing the condition beyond traditional medication. Unlike standard antiretroviral therapies that focus on controlling the virus, high-intensity interval training (HIIT) could improve cardiovascular fitness, muscle strength, and overall quality of life. Meanwhile, continuous moderate-intensity exercise (CME) provides a more sustainable, less intense option that may still yield significant health benefits. This trial aims to uncover how these exercise regimens can complement existing treatments, potentially leading to a more holistic approach to HIV management in older populations.
What evidence suggests that this trial's treatments could be effective for older adults with HIV?
Research has shown that high-intensity interval training (HIIT), one of the treatments studied in this trial, can significantly boost fitness levels in older adults living with HIV. One study found a 17% increase in VO2peak, which measures how efficiently the body uses oxygen, in participants with an average age of 63, indicating improved heart and lung function. Another study found that HIIT is feasible and can enhance overall health, including brain function, in older people with HIV. These findings suggest that HIIT might reduce tiredness and improve physical abilities in this group. This trial will also evaluate continuous moderate-intensity exercise (CME) as another treatment option to compare its effects on fitness and health outcomes in older adults with HIV.12467
Who Is on the Research Team?
Kristine Erlandson, MD, MS
Principal Investigator
University of Colorado, Denver
Allison Webel, PhD, RN
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for adults aged 50-80 with HIV who are sedentary, experience fatigue, and have been on stable antiretroviral therapy with a controlled viral load. They must be willing to commit to a 16-week exercise program and have no major health issues like severe heart disease or uncontrolled diabetes that could interfere with safe participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either high-intensity interval training (HIIT) or continuous moderate-intensity exercise (CME) to assess physical function and fatigue
Follow-up
Participants are monitored for adherence to physical activity and long-term effects of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- CME
- HIIT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
University of Washington
Collaborator
Case Western Reserve University
Collaborator